tradingkey.logo

Co-Diagnostics Inc

CODX

0.261USD

+0.013+5.20%
Horarios del mercado ETCotizaciones retrasadas 15 min
8.77MCap. mercado
PérdidaP/E TTM

Co-Diagnostics Inc

0.261

+0.013+5.20%
Más Datos de Co-Diagnostics Inc Compañía
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Información de la empresa
Símbolo de cotizaciónCODX
Nombre de la empresaCo-Diagnostics Inc
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoMr. Dwight H. Egan
Número de empleados132
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 12
Dirección2401 S. Foothill Dr. Suite D
CiudadSALT LAKE CITY
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal84109
Teléfono18014381036
Sitio Webhttp://codiagnostics.com/
Símbolo de cotizaciónCODX
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoMr. Dwight H. Egan
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
272.50K
+21.56%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
262.50K
+22.57%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
272.50K
+21.56%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
262.50K
+22.57%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
40.18K
79.91%
Rest of the world
10.10K
20.09%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
5.27%
Private Advisory Group LLC
3.50%
Egan (Dwight H.)
2.22%
Abbott (Richard David)
1.87%
Brown (Brian Lee)
1.78%
Other
85.35%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
5.27%
Private Advisory Group LLC
3.50%
Egan (Dwight H.)
2.22%
Abbott (Richard David)
1.87%
Brown (Brian Lee)
1.78%
Other
85.35%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
12.53%
Individual Investor
9.00%
Hedge Fund
2.28%
Investment Advisor/Hedge Fund
2.16%
Research Firm
0.35%
Venture Capital
0.14%
Other
73.53%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
94
8.93M
26.47%
-27.21K
2025Q1
104
8.10M
24.04%
-1.01M
2024Q4
112
7.90M
24.75%
+252.58K
2024Q3
117
6.36M
19.95%
-1.22M
2024Q2
133
6.56M
20.58%
-1.41M
2024Q1
141
5.44M
17.41%
-2.70M
2023Q4
150
5.77M
18.52%
-2.36M
2023Q3
166
5.34M
17.40%
-3.33M
2023Q2
189
5.25M
17.04%
-4.29M
2023Q1
236
6.05M
19.75%
-4.89M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
1.78M
5.27%
--
--
Mar 31, 2025
Private Advisory Group LLC
1.18M
3.5%
--
--
Mar 31, 2025
Egan (Dwight H.)
748.18K
2.22%
+111.64K
+17.54%
May 23, 2025
Abbott (Richard David)
631.47K
1.87%
+12.82K
+2.07%
May 23, 2025
Brown (Brian Lee)
599.30K
1.78%
+86.00K
+16.76%
May 23, 2025
Renaissance Technologies LLC
550.32K
1.63%
-5.30K
-0.95%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
496.73K
1.47%
-1.44K
-0.29%
Mar 31, 2025
Geode Capital Management, L.L.C.
342.17K
1.01%
-3.34K
-0.97%
Mar 31, 2025
Bridgeway Capital Management, LLC
272.90K
0.81%
--
--
Mar 31, 2025
Nelson (James B)
272.50K
0.81%
+48.33K
+21.56%
May 23, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI